← Banking With Billy News

Definium Therapeutics said its first Phase 3 trial of DT120 ODT in generalized anxiety disorder met topline goals. The result marks a second consecutive positiv

BWB News TV • 2026-08-12 11:11 UTC • By Billy Odell Tucker-Robinson
Definium Therapeutics said its first Phase 3 trial of DT120 ODT in generalized anxiety disorder met topline goals. The result marks a second consecutive positiv
Definium Therapeutics said its first Phase 3 trial of DT120 ODT in generalized anxiety disorder met topline goals. The result marks a second consecutive positive pivotal study, strengthening the case for regulatory next steps.
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly